Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction

BACKGROUND: Management of diabetes mellitus-induced erectile dysfunction (DMED) is challenging because of its insufficient responses to phosphodiesterase type 5 inhibitors. AIM: To compare the effects of ipidacrine, a reversible cholinesterase inhibitor, and sildenafil on DMED in a rat model of stre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bykov, Vladimir, Gushchina, Evgenia, Morozov, Sergey, Zhuravskaya, Natalia, Kryshen, Kirill, Makarov, Valery, Matichin, Aleksandr, Zueva, Alena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847829/
https://www.ncbi.nlm.nih.gov/pubmed/35007992
http://dx.doi.org/10.1016/j.esxm.2021.100477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847829/
https://www.ncbi.nlm.nih.gov/pubmed/35007992
http://dx.doi.org/10.1016/j.esxm.2021.100477

Ejemplares similares